Publications by authors named "Oliver Frenzel"

Claim this Profile
C
Community pharmacists' engagement in opioid harm reduction: A rural-urban analysis from a rural state.
Elizabeth Skoy, Oliver Frenzel, Elizabell Delgado, Jenna Gorder, Landon Woinarowicz

J Rural Health· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Community Pharmacy Opioid Risk Screening Assessments: Comparing older adults (65+) to those under 65.
Oliver Frenzel, Jayne Steig, Elizabell Delgado, Heidi Eukel

Sr Care Pharm· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dare 2 Discuss social media campaign: An educational initiative to improve opioid use disorder discussions between the pharmacist and patient.
Oliver Frenzel, Isaiah Ratz, Anna Skarphol, Amy Werremeyer

J Am Pharm Assoc (2003)· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Implementation of a North Dakota opioid misuse and overdose prevention program in West Virginia.
Elizabeth Skoy, Rebecca Linger, Heidi Eukel, Susan Murphy, Oliver Frenzel

J Am Pharm Assoc (2003)· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Revisiting the opioid and naloxone education (ONE) program: Program evaluation using the RE-AIM model four years later.
Mark A Strand, Oliver Frenzel

Res Social Adm Pharm· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessing a Medication Safety and Disposal Educational Program using the Health Belief Model.
Oliver Frenzel, Jayme Steig, Alyssa Hodges

Innov Pharm· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Implementation of a Pharmacy Follow-Up Program for Dispensed Opioid Medications.
Elizabeth Skoy, Oliver Frenzel, Haley Pajunen, Heidi Eukel

Int J Environ Res Public Health· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Longitudinal Comparison of Pharmacy Documentation Platforms Using the Technology Acceptance Model: Experiences With Opioid Risk Screening.
Oliver C Frenzel, Mark Strand, Allison Welsh, Heidi Eukel, Elizabeth Skoy

J Pharm Technol· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Opioid risk stratification in the community pharmacy: The utility of the Opioid Risk Tool.
Mark A Strand, Heidi N Eukel, Oliver Frenzel, Elizabeth Skoy, Jayme Steig

Res Social Adm Pharm· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improving Community Pharmacist-Delivered Care for Patients With Psychiatric Disorders Filling an Opioid Prescription.
Amy Werremeyer, Oliver Frenzel, Mark A Strand, Heidi Eukel, Elizabeth Skoy

Psychiatr Serv· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of a Program to Screen Patients in Community Pharmacies for Opioid Misuse and Accidental Overdose.
Elizabeth Skoy, Oliver Frenzel, Heidi Eukel, Emily Lothspeich, Jayme Steig

Prev Chronic Dis· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Opioid risk screening: Program evaluation from the community pharmacists' perspective.
Oliver Frenzel, Heidi Eukel, Emily Lothspeich, Elizabeth Skoy, Jayme Steig

J Am Pharm Assoc (2003)· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Longitudinal evaluation of pharmacists' social distance preference and attitudes toward patients with opioid misuse following an educational training program.
Amy Werremeyer, Mark A Strand, Heidi Eukel, Elizabeth Skoy, Jayme Steig, Oliver Frenzel

Subst Abus· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient acceptance of naloxone resulting from targeted intervention from community pharmacists to prevent opioid misuse and accidental overdose.
Elizabeth Skoy, Amy Werremeyer, Jayme Steig, Heidi Eukel, Oliver Frenzel

Subst Abus· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacists' stigma toward patients engaged in opioid misuse: When "social distance" does not mean disease prevention.
Amy Werremeyer, Sydney Mosher, Heidi Eukel, Elizabeth Skoy, Jayme Steig, Oliver Frenzel

Subst Abus· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Opioid Misuse and Overdose: Changes in Pharmacist Practices and Outcomes.
Heidi Eukel, Jayme Steig, Oliver Frenzel, Elizabeth Skoy, Amy Werremeyer

J Contin Educ Health Prof· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Implementation of a statewide program within community pharmacies to prevent opioid misuse and accidental overdose.
Elizabeth Skoy, Heidi Eukel, Amy Werremeyer, Mark Strand, Oliver Frenzel

J Am Pharm Assoc (2003)· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Regarding "Pharmacists are missing opportunities to save lives and advance the profession by embracing opioid harm reduction".
Oliver Frenzel, Mark A Strand, David R Bright, Natalie A DiPietro Mager

J Am Pharm Assoc (2003)· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Examining Attitudes and Beliefs that Inhibit Pharmacist Implementation of a Statewide Opioid Harm Reduction Program.
Oliver C Frenzel, Heidi Eukel, Elizabeth Skoy, Amy Werremeyer, Jayme Steig

Innov Pharm· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Program evaluation of the Opioid and Naloxone Education (ONE Rx) program using the RE-AIM model.
Mark A Strand, Heidi Eukel, Oliver Frenzel, Elizabeth Skoy, Jayme Steig

Res Social Adm Pharm· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis